Cancers can spread to the lung causing fluid build-up and requires drainages in hospital that are painful and costly. Surgery is previously seen as the definitive option to stop fluid forming, but is invasive with complications. Indwelling pleural catheter (IPC) is a novel implanted device inside the chest that allows patients to drain fluid at home. AMPLE Trial-3 is the first multicenter randomized clinical trial to compare surgery vs IPC to provide fluid control and improve quality of life.
How Does The Endometrium Regenerate? Role Of Epithelial Stem/progenitor Cells
Funder
National Health and Medical Research Council
Funding Amount
$663,397.00
Summary
Endometriosis and endometrial cancer are disorders of endometrial growth and regeneration. We recently discovered adult stem cells in the endometrium (uterine lining), which are responsible for its regeneration each month during the menstrual cycle. We aim to examine the role of a molecular pathway in endometrial epithelial stem cell function during endometrial regeneration to identify novel targets for devising more effective non-hormonal therapies for endometriosis and endometrial cancer.
Mediator Kinase As A Therapeutic Target For Wnt/β-catenin Dependent Malignancies
Funder
National Health and Medical Research Council
Funding Amount
$949,907.00
Summary
Colorectal cancer is the third leading cause of cancer mortality in Australia and globally. The Wnt/?-catenin signalling pathway is a well established driver of colon cancer growth in >90% of cases. Using sophisticated genetic screens, we identified CDK8/19 as a colon cancer oncogene and critical regulator of Wnt/?-catenin activity. In this proposal, we will use innovative cancer models in mice and human cancer tissues to investigate newly developed CDK8/19 inhibitors for colon cancer therapy ....Colorectal cancer is the third leading cause of cancer mortality in Australia and globally. The Wnt/?-catenin signalling pathway is a well established driver of colon cancer growth in >90% of cases. Using sophisticated genetic screens, we identified CDK8/19 as a colon cancer oncogene and critical regulator of Wnt/?-catenin activity. In this proposal, we will use innovative cancer models in mice and human cancer tissues to investigate newly developed CDK8/19 inhibitors for colon cancer therapy.Read moreRead less
Characterising The Function Of Niche-derived Neuregulin 1 In Colorectal Cancer
Funder
National Health and Medical Research Council
Funding Amount
$994,246.00
Summary
Colorectal cancer affects thousands of Australians each year. A specialised cell population, named cancer stem cells, continuously produces new tumour cells. Defining mechanisms controlling the behaviour of these unique cells is critical to develop new drugs. We have identified that Neuregulin-1 is a key factor that enhances the action of cancer stem cells. We aim to study how colorectal cancer is mediated and whether targeting Neuregulin-1 is a promising therapeutic option.
A Population-based Longitudinal Study Of Cancer Survivors' Psychosocial And Physical Well Being
Funder
National Health and Medical Research Council
Funding Amount
$454,600.00
Summary
Cancer control is a National Health Priority Area. About 345,000 new cases of cancer are diagnosed in Australia each year. It is the second highest cause of death accounting for 27% of all deaths in Australia each year. Improvements in diagnosis and treatment have resulted in a growing number of people living with a history of cancer and for longer periods. Many cancer survivors report experiencing negative effects of cancer such as fatigue, anxiety, depression, and disrupted family and social r ....Cancer control is a National Health Priority Area. About 345,000 new cases of cancer are diagnosed in Australia each year. It is the second highest cause of death accounting for 27% of all deaths in Australia each year. Improvements in diagnosis and treatment have resulted in a growing number of people living with a history of cancer and for longer periods. Many cancer survivors report experiencing negative effects of cancer such as fatigue, anxiety, depression, and disrupted family and social relationships well after treatment has finished. Despite the large burden of this disease, little is known about the later effects that cancer and its treatment has on cancer survivors, their ongoing concerns, how the issues they face change over time and the type of support they need. This will be the first population-based longitudinal survey of the physical and psychosocial effects that cancer has on adult cancer survivors to be undertaken in Australia. It will follow cancer survivors for the first five years from diagnosis to provide data on important outcomes including anxiety, depression, quality of life and unmet needs. It will also provide the first population-based data on the predictors of these outcomes, including social support, coping style and patient demographic, treatment and disease characteristics. Given the large-scale cancer survivorship initiatives underway internationally, it is timely for high quality and comprehensive Australian data to be obtained. These data will provide new information on how the physical, social and emotional impact of cancer changes with time since diagnosis and a better understanding of the support desired by cancer survivors at various stages of recovery or disease progression. This information will help guide the development of policies and services that are tailored to the needs of Australian cancer survivors.Read moreRead less
Computational And Statistical Methods For The Analysis Of RNA-Seq Data
Funder
National Health and Medical Research Council
Funding Amount
$406,545.00
Summary
New sequencing technologies provide medical researchers with ultra high-resolution tools for measuring gene activity in healthy and diseased cells. These instruments generate unprecedented volumes of data that requires careful analysis to maximize the biological insight learned from each experiment. Our research will develop new tools for analyzing, interpreting and making medical discoveries from this rapidly emerging technology, for the benefit of Australian biomedical researchers.
There is evidence that elderly cancer patients are often inappropriately treated because of their age. This is usually because of concerns that aged patients can not eliminate drugs as well as the young and, as a result, could end up being overdosed. Some drugs are removed from the body through the urine and adjusting for decreased kidney function (which often decreases with age) means that adequate doses can be calculated. However, many anti-cancer drugs are removed from the body by being broke ....There is evidence that elderly cancer patients are often inappropriately treated because of their age. This is usually because of concerns that aged patients can not eliminate drugs as well as the young and, as a result, could end up being overdosed. Some drugs are removed from the body through the urine and adjusting for decreased kidney function (which often decreases with age) means that adequate doses can be calculated. However, many anti-cancer drugs are removed from the body by being broken down (or metabolised) in the liver. The rate of this process is very difficult to estimate. Although many studies have shown that liver drug metabolism is decreased with age, it is unclear whether this is due strictly to age itself or some of the conditions which accompany ageing. We aim to study the removal of anti-cancer drugs in patients treated for cancer to see what the effects of ageing are. We will estimate the extent of liver breakdown and examine whether it is a function of age or rather of several factors which are often associated with age such as inflammation, reduced nutritional status and other medical conditions. The optimal outcome of the study will be methods for correctly adjusting the dose of anticancer drugs for maximal benefit to the elderly patient.Read moreRead less
Thousands of chemicals are used in Australian workplaces. For many of these chemicals it is not known if they are harmful to people who work with them. Unless we can measure how much of a chemical a worker has been exposed to, we cannot determine if the chemical is harmful. While we can test what chemicals a worker is currently exposed to, it is more difficult to estimate how much chemical exposure they have had in the past. This project aims to improve the ways we estimate past chemical exposur ....Thousands of chemicals are used in Australian workplaces. For many of these chemicals it is not known if they are harmful to people who work with them. Unless we can measure how much of a chemical a worker has been exposed to, we cannot determine if the chemical is harmful. While we can test what chemicals a worker is currently exposed to, it is more difficult to estimate how much chemical exposure they have had in the past. This project aims to improve the ways we estimate past chemical exposure. We will build on existing best-practice methods to improve occupational exposure assessment. New computer technology will be used to develop an intelligent evolving database that can be used when asking people about jobs they have had in the past. Experts can examine the answers to the questions to decide whether the worker was exposed to particular chemicals. New methods of processing information, called artificial neural networks, will be used to automate some of these decisions.Read moreRead less